|
Volumn 98, Issue 18, 1998, Pages 1949-1984
|
Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee on management of patients with valvular heart disease)
a a a a a a a a a a a a |
Author keywords
AHA Medical Scientific Statements; Mitral valve; Regurgitation; Stenosis; Valves
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANOREXIGENIC AGENT;
ANTICOAGULANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DEXFENFLURAMINE;
DIGITALIS;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOBUTAMINE;
FENFLURAMINE;
GENTAMICIN;
HEPARIN;
NITROPRUSSIDE SODIUM;
PHENTERMINE;
VANCOMYCIN;
VASODILATOR AGENT;
WARFARIN;
ADOLESCENT;
ADULT;
ANTIBIOTIC PROPHYLAXIS;
AORTA STENOSIS;
AORTA VALVE REGURGITATION;
BACTERIAL ENDOCARDITIS;
CORONARY ARTERY DISEASE;
DENTAL SURGERY;
ECHOCARDIOGRAPHY;
EXERCISE TEST;
FOLLOW UP;
HEART ATRIUM FIBRILLATION;
HEART CATHETERIZATION;
HEART MURMUR;
HEART VALVE PROSTHESIS;
HUMAN;
INTRAMUSCULAR DRUG ADMINISTRATION;
INTRAVENOUS DRUG ADMINISTRATION;
MARFAN SYNDROME;
MITRAL VALVE PROLAPSE;
MITRAL VALVE REGURGITATION;
MITRAL VALVE STENOSIS;
PRACTICE GUIDELINE;
PREGNANCY;
PRIORITY JOURNAL;
PULMONARY VALVE STENOSIS;
REVIEW;
RHEUMATIC FEVER;
SCINTIANGIOGRAPHY;
THROMBOEMBOLISM;
TRICUSPID VALVE DISEASE;
VALVULAR HEART DISEASE;
|
EID: 0032480758
PISSN: 00097322
EISSN: None
Source Type: Journal
DOI: 10.1161/01.CIR.98.18.1949 Document Type: Review |
Times cited : (840)
|
References (9)
|